Chevron Left
Back to Disease Screening in Public Health

Learner Reviews & Feedback for Disease Screening in Public Health by University of Geneva

4.5
stars
357 ratings
87 reviews

About the Course

Current and future public health is characterized by the increase of chronic and degenerative diseases, corresponding to the worldwide ageing of the population. The increasing prevalence of these conditions together with the long incubation period of the chronic diseases and the continual technological innovations, offer new opportunities to develop strategies for early diagnosis. Public Health has an important mandate to critically assess the promises and the pitfalls of disease screening strategies. This MOOC will help you understand important concepts for screening programs that will be explored through a series of examples that are the most relevant to public health today. We will conclude with expert interviews that explore future topics that will be important for screening. By the end of this MOOC, students should have the competency needed to be involved in the scientific field of screening, and understand the public health perspective in screening programs. This MOOC has been designed by the University of Geneva and the University of Lausanne. This MOOC has been prepared under the auspices of the Ecole romande de santé publique (www.ersp.ch) by Prof. Fred Paccaud, MD, MSc, Head of the Institute of Social and Preventive Medicine in Lausanne (www.iumsp.ch), in collaboration with Professor Antoine Flahault, MD, PhD, head of the Institute of Global Health, Geneva (https://www.unige.ch/medecine/isg/en/) and Prof. Gillian Bartlett-Esquilant (McGill University, Quebec/ Institute of Social and Preventive Medicine, Lausanne)....

Top reviews

PB
Jun 22, 2021

It is a wonderful course and it help me to improve my skill, providing the very interesting methods in disease screening and implementation. How to evaluate a screening process is also learned.

SH
Aug 24, 2020

To all the course professors: " A wonderful and big thank you for a course well taught and well completed by myself." I have learnt alot. Samantha Henry (Rotary Ambassadorial Scholar). Guyana

Filter by:

51 - 75 of 87 Reviews for Disease Screening in Public Health

By Jayagandan J

Jun 20, 2020

Handcrafted for working professionals.

By Camille K S R

Mar 8, 2018

Very good, very useful and well done

By Flavio I P

Apr 22, 2020

Un corso davvero di alto livello.

By Abdul R

Apr 16, 2020

This course is quite informative.

By victor A

Aug 24, 2020

It improves public health

By Mohammed H H

Jun 9, 2020

Very informative course

By Lefika T K

May 10, 2020

Its a very good course

By DR S H

Apr 18, 2020

Excellent course

By Lakshmi P

Jun 30, 2020

very nice course

By Siddharth R

May 23, 2020

excellent course

By Salvador O G

Jul 21, 2017

excellent course

By MOHAMMAD G A A

Dec 31, 2020

Amazing course

By MD A R A

Aug 4, 2020

Excellent !!!

By Raghad A

Aug 15, 2020

great course

By Manjeet S

Jul 29, 2020

great course

By B A

May 14, 2020

Great corse!

By Manoj K P

Apr 24, 2020

Wonderful.

By Carlos A

May 28, 2020

Thank you

By Dr A a

Apr 21, 2020

Great

By Bibi B R V

Sep 24, 2020

Good

By Sriskantharajah V

Jun 4, 2020

good

By USHASREE P

May 14, 2020

GOOD

By Dr. M B

May 10, 2020

good

By sutasinee t

May 4, 2020

good

By Bryan F

Jul 12, 2020

A more appropriate Title for this would have been: ~A course detailing measures that check the quality, performance, or reliability of screening processes. The course is all about testing the screening method, and not so much what KINDS of tests are in use for say, COVID-19. What tests are in use today for screening diseases and how do they work ? That is not in this course. That said, once you realize this course does not go anywhere near what disease tests actually do, and you are locked in to the course then yes it is very useful. Public health professionals accept reliability of the 2 types of COVID-19 screenings, and have their hands full completing the task of disease screening of the public for virus and, since most screening is by off the shelf purchases from pharmaceutical companies, twho is the audience intended for this course? It seems to me this course would be most useful for screening test designers at the Pharmaceuticals. It is for inventors of screening tests, who want to verify reliability, before put their screening test on the market, for public health agencies. The coursed was challenging and very interesting once you accept that the course is about, testing the tests. Thank you.